Delivery Order SPE2DB20D9329-SPE2DB25FZK39
Award Date 6/11/25
Potential Completion Date 6/12/25
Potential Value $1.1K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order on September 4, 2025, by the Defense Logistics Agency for the supply of Boostrix TDAP vaccine syringes (0.5ML) with a ceiling value of $18,152.32. This firm fixed-price delivery order, which must be completed by September 5, 2025, represents a routine pharmaceutical supply transaction under DMS Pharmaceutical Group's existing Indefinite Delivery...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order on August 27, 2025, by the Defense Logistics Agency for the supply of Boostrix TDAP vaccine in 0.5 mL syringes. The contract carries a ceiling value of $17,048.40 and is structured as a firm fixed-price delivery order with an ultimate completion date of August 28, 2025. No set-aside designation was utilized for this award, and the place of...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,988.98 to DMS Pharmaceutical Group Inc. on June 3, 2025, with an ultimate completion date of June 4, 2025. The delivery order is for Boostrix TDAP vaccine syringes in 0.5mL dosages, to be delivered to Park Ridge, Illinois. This contract utilizes a firm fixed-price structure with no set-aside designation. The award represents a single delivery order issued under DMS Pharmaceutical Group's existing Indefinite Delivery...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $5,114.52 to DMS Pharmaceutical Group Inc. for the supply of Boostrix TDAP vaccine in 0.5mL syringes. DMS Pharmaceutical Group, a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, will perform this contract at its facility in Park Ridge. The delivery order was issued on August 7, 2025, with an ultimate completion date of August 8, 2025, and no set-aside designation was...
- The Defense Logistics Agency (DLA) awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Boostrix TDAP vaccine syringes (0.5mL) under a firm fixed-price contract. This delivery order, valued at $13,922.86 with an ultimate completion date of July 21, 2025, was issued without a set-aside designation. The award leverages DMS Pharmaceutical Group's position as a critical supplier within the...
- This is a $28,696.68 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The order is for the BOOSTRIX TDAP vaccine syringe, 0.5 mL, with a completion date of June 14, 2024. DMS Pharmaceutical Group holds a significant $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows the agency to issue delivery orders...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $6,815.90 firm fixed-price contract is for the procurement of BOOSTRIX TDAP VACCINE SYRINGE 0.5ML, a pharmaceutical product, with a period of performance ending on January 17, 2025. DMS Pharmaceutical Group Inc. holds a significant $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, enabling the...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order valued at $21,878.78 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Boostrix TDAP vaccine in 0.5 mL syringes. The contract, awarded on August 13, 2025, with an ultimate completion date of August 14, 2025, carries no set-aside designation. DMS Pharmaceutical Group will perform this work at its Park Ridge facility and deliver the...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $3,693.82 to DMS Pharmaceutical Group Inc. for the supply of Boostrix TDAP vaccine in 0.5mL syringes. The contract, effective July 23, 2025, with an ultimate completion date of July 24, 2025, represents a delivery order issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA valued at $499,999,999 and valid through November 2026. No set-aside designation was applied to this award. The...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $4,546.24 to DMS Pharmaceutical Group Inc. for the supply of Boostrix TDAP vaccine in 0.5mL syringes. The order was executed on June 18, 2025, with an ultimate completion date of June 20, 2025, and is to be performed in Park Ridge, Illinois. This delivery order was issued without set-aside designation and represents a routine pharmaceutical product fulfillment within DMS Pharmaceutical Group's broader federal supply...